全文获取类型
收费全文 | 4104篇 |
免费 | 272篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 118篇 |
妇产科学 | 93篇 |
基础医学 | 778篇 |
口腔科学 | 135篇 |
临床医学 | 337篇 |
内科学 | 717篇 |
皮肤病学 | 138篇 |
神经病学 | 614篇 |
特种医学 | 138篇 |
外科学 | 402篇 |
综合类 | 22篇 |
一般理论 | 2篇 |
预防医学 | 250篇 |
眼科学 | 67篇 |
药学 | 304篇 |
中国医学 | 2篇 |
肿瘤学 | 255篇 |
出版年
2023年 | 38篇 |
2022年 | 52篇 |
2021年 | 96篇 |
2020年 | 81篇 |
2019年 | 112篇 |
2018年 | 99篇 |
2017年 | 72篇 |
2016年 | 110篇 |
2015年 | 128篇 |
2014年 | 166篇 |
2013年 | 166篇 |
2012年 | 310篇 |
2011年 | 333篇 |
2010年 | 192篇 |
2009年 | 189篇 |
2008年 | 312篇 |
2007年 | 293篇 |
2006年 | 285篇 |
2005年 | 245篇 |
2004年 | 288篇 |
2003年 | 240篇 |
2002年 | 215篇 |
2001年 | 27篇 |
2000年 | 26篇 |
1999年 | 37篇 |
1998年 | 40篇 |
1997年 | 36篇 |
1996年 | 27篇 |
1995年 | 25篇 |
1994年 | 28篇 |
1993年 | 21篇 |
1992年 | 14篇 |
1991年 | 11篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1987年 | 3篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1982年 | 2篇 |
1980年 | 2篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1968年 | 6篇 |
1960年 | 2篇 |
1956年 | 6篇 |
1948年 | 4篇 |
1947年 | 2篇 |
1944年 | 2篇 |
排序方式: 共有4393条查询结果,搜索用时 15 毫秒
71.
Libani IV Guy EC Melchiori L Schiro R Ramos P Breda L Scholzen T Chadburn A Liu Y Kernbach M Baron-Lühr B Porotto M de Sousa M Rachmilewitz EA Hood JD Cappellini MD Giardina PJ Grady RW Gerdes J Rivella S 《Blood》2008,112(3):875-885
In β-thalassemia, the mechanism driving ineffective erythropoiesis (IE) is insufficiently understood. We analyzed mice affected by β-thalassemia and observed, unexpectedly, a relatively small increase in apoptosis of their erythroid cells compared with healthy mice. Therefore, we sought to determine whether IE could also be characterized by limited erythroid cell differentiation. In thalassemic mice, we observed that a greater than normal percentage of erythroid cells was in S-phase, exhibiting an erythroblast-like morphology. Thalassemic cells were associated with expression of cell cycle–promoting genes such as EpoR, Jak2, Cyclin-A, Cdk2, and Ki-67 and the antiapoptotic protein Bcl-XL. The cells also differentiated less than normal erythroid ones in vitro. To investigate whether Jak2 could be responsible for the limited cell differentiation, we administered a Jak2 inhibitor, TG101209, to healthy and thalassemic mice. Exposure to TG101209 dramatically decreased the spleen size but also affected anemia. Although our data do not exclude a role for apoptosis in IE, we propose that expansion of the erythroid pool followed by limited cell differentiation exacerbates IE in thalassemia. In addition, these results suggest that use of Jak2 inhibitors has the potential to profoundly change the management of this disorder. 相似文献
72.
de Vries-Sluijs TE Hansen BE van Doornum GJ Springeling T Evertsz NM de Man RA van der Ende ME 《The Journal of infectious diseases》2008,197(2):292-294
Double-dose hepatitis B virus revaccination of human immunodeficiency virus (HIV)-infected patients proved to be effective in 50.7% of 144 patients who had previously failed to respond to standard doses. In the multivariate analysis, female patients were found to have a significantly better response (P= .03). The effect of age on the response depended on the viral load at the time of revaccination. For patients with a detectable HIV RNA load, the effect of age was stronger (odds ratio [OR], 0.34 per 10 years older [95% confidence interval {CI}, 0.16-0.72]; P= .005) than for patients with an undetectable HIV RNA load (OR, 0.74 per 10 years older [95% CI, 0.50-1.09]; P= .12). 相似文献
73.
74.
75.
Paul Declerck Georgios Bakalos Elias Zintzaras Bettina Barton Thomas Schreitmüller 《Clinical therapeutics》2018,40(5):798-809.e2
Purpose
With the introduction of biosimilars of anticancer monoclonal antibodies (mAbs) in oncology, physicians are potentially confronted with the question whether it is clinically adequate to switch patients who are clinically stable on treatment with the reference product to a newly available biosimilar (or vice versa/from 1 biosimilar to another). For a proper impact assessment of switching, robust, product-specific, and clinically relevant evidence should be required, ideally including data from appropriately designed switching studies. In this article, we assess the current body of switching data available for approved or proposed biosimilars of anticancer mAbs.Methods
PubMed was systematically searched and ClinicalTrials.gov and abstract databases of selected congresses were hand-searched to identify all switching studies including biosimilars of anticancer mAbs.Findings
We identified 8 switching studies with biosimilars of rituximab (CT-P10, GP2013, PF-05280586, and BCD-020) and trastuzumab (ABP 980). Two were performed in oncology indications and the other 6 in rheumatoid arthritis (RA). Key elements of a well-designed switching study, such as randomization and blinding, were contained in several of the studies, but significant limitations were also present. The most frequent limitations were low statistical power because of small patient numbers, lack of an appropriate control arm, short follow-up, chosen outcome measures, and (for studies performed in RA) the concern whether switching data can be extrapolated to oncology indications. Accordingly, the data from these studies need to be interpreted with caution. Of note, all identified studies included a single switch only, whereas multiple switches may occur in the real-world setting. The scientific need to evaluate the impact of repeated switching has been recognized by the US Food and Drug Administration, who incorporated such a requirement in its draft guidance on interchangeability.Implications
From the scarce data available, the consequences of switching between reference product mAbs and their biosimilar(s) in the oncology setting are as yet unknown. Additional clinical evidence from well-designed switching studies is needed to guide switching decisions. 相似文献76.
77.
Purpose
Choroidal neovascularization (CNV) associated with punctate inner choroidopathy (PIC) is a rare clinical entity, yet still a challenge for medical treatment. A case of a young myopic woman developing CNV secondary to unilateral PIC is presented. Clinical morphology, diagnostic procedure and follow-up are reported.Case Report
A 29-year-old woman presented with multiple yellowish dots at the posterior pole. No other signs of inflammation could be seen. Angiography with fluorescein yielded hyperfluorescent signals in the affected areas with a diffuse leak, and SD-OCT showed a slightly elevated retinal pigment epithelial layer, consistent with the diagnosis of PIC. Additionally a classic CNV was observed.Results
Anti-inflammatory therapy with local prednisolone acetate eye drops in combination with intravitreal injection of anti-vascular endothelial growth factor (VEGF, bevacizumab) yielded an increased best-corrected visual acuity. As CNV reappeared, systemic medication with prednisone and azathioprine in combination with two further intravitreal injections of anti-VEGF stabilized CNV and increased visual acuity again.Conclusion
Combined therapy of immunosuppression with intravitreal anti-VEGF injections can be considered as therapeutic strategy in the management of recurrent CNV associated with PIC.Key Words: Punctate inner choroidopathy, Choroidal neovascularization, Intravitreal anti-VEGF therapy, Choroiditis 相似文献78.
Limperger Verena Kenet Gili Kiesau Bettina Köther Max Schmeiser Malin Langer Florian Juhl David Shneyder Maria Franke Andre Klostermeier Ulrich K. Mesters Rolf Rühle Frank Stoll Monika Steppat Dagmar Kowalski Dorothee Rocke Angela Kuta Piotr Bajorat Tido Torge Antje Neuner Bruno Junker Ralf Nowak-Göttl Ulrike 《Journal of thrombosis and thrombolysis》2021,51(2):494-501
Journal of Thrombosis and Thrombolysis - The role of the A>G polymorphism at position 19911 in the prothrombin gene (factor [F] 2 at rs3136516) as a risk factor for venous thromboembolism... 相似文献
79.
Atila Cihan Monnerat Sophie Urwyler Sandrine Andrea Refardt Julie Winzeler Bettina Christ-Crain Mirjam 《Pituitary》2022,25(4):636-644
Pituitary - Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not... 相似文献
80.
Christian-Hendrik Heeger MD Jan-Eric Bohnen MD Sorin Popescu Roza Meyer-Saraei PhD Thomas Fink MD Vanessa Sciacca Bettina Kirstein MD Sascha Hatahet MD Anna Traub MD Lisbeth D. Lopez MD Michael Schlüter Karl-Heinz Kuck MD Charlotte Eitel MD Julia Vogler MD Roland Richard Tilz MD 《Journal of cardiovascular electrophysiology》2021,32(6):1553-1560